ArticleBMC genomics2026
Transcriptomic analysis of Atractylodes lancea (Thunb.) DC under methyl jasmonate induction reveals the terpene synthase genes related to sesquiterpenoid biosynthesis.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundMethyl jasmonate (MeJA) serves as a potent elicitor of plant specialized metabolism, including terpenoid biosynthesis. The medicinal rhizome of Atractylodes lancea, renowned in traditional Chinese medicine, synthesizes pharmaceutically active sesquiterpenoids responsible for its therapeutic efficacy against rheumatic diseases, digestive disorders, and night blindness. However, the molecular understanding of MeJA-mediated sesquiterpene biosynthesis in A. lancea is not clear. Thus, it is important to explore the molecular mechanism and genes involved in sesquiterpene biosynthesis pathway underlying the response of A. lancea to MeJA.
resultsCombining MeJA elicitation with transcriptome profiling, we identified 25 sesqui-terpenoids synthase (AlTPS) gene in A. lancea via KEGG enrichment analysis and conserved motif analysis. Correlation analysis between DEGs and sesquiterpenoid accumulation, coupled with phylogenetic assessment, identified AlTPS7 and AlTPS8 as prime candidates, showing close homology to the characterized β-eudesmol synthase ZmZSS2. Functional characterization revealed that AlTPS8 could catalyze the conversion of FPP into β-caryophyllene, with a small amount of α-caryophyllene as a byproduct, whereas AlTPS7 was enzymatically inactive. Notably, quantitative analysis revealed AlTPS8’s superior catalytic efficiency, producing β-caryophyllene at 3.14-fold higher titers (0.36 ± 0.04 mg/L) than our previously characterized AlTPS6*, as quantified by in vivo product accumulation. Structural modeling and mutagenesis analyses revealed four key divergent residues (ALA398, SER402, THR449, ASN525) in AlTPS6* that regulate functional divergence, with the substitution of ASN525 to ASP being critical for enhancing catalytic efficiency.
conclusionsThese results provide mechanistic insights into MeJA-responsive sesquiterpenoid biosynthesis in A. lancea and a genetic toolkit for metabolic engineering of high-value medicinal terpenoids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.